phase readout
saveNCT05711719: Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
COMPLETEDupdated 2mo ago
community read0 votes
Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Metabolic Syndrome, Coronary Microvascular Dysfunction
view source ↗
comments(0)
5-min edit window · permanent after that